GSPInsider The company markets three products: Cleviprex (clevidipine butyrate) injectable emulsion Angiomax (bivalirudin), as well as a ready-to-use formulation of Argatroban . In addition to this, it has a pipeline of intensive and acute- care hospital products ...
DailyFinance "These improvements were driven in particular by long-term partnerships coming to commercial fruition, most notably significant sales of enzymes to Merck and stepped up collaborative revenue for argatroban injection through our partnership with Exela ...
Business Wire (press release) “These improvements were driven in particular by long-term partnerships coming to commercial fruition, most notably significant sales of enzymes to Merck and stepped up collaborative revenue for argatroban injection through our partnership with Exela ... and more »
Seeking Alpha Our pharma results in the first quarter were also bolstered by our longstanding collaboration with the specialty pharma company Exela Pharma Sciences and its partnership with Hikma Pharmaceutical for the development of argatroban injection. As a result ...
Motley Fool A one-time milestone payment of $1 million was also received from partner Exela Pharma, which uses Codexis enzymes for its newly approved argatroban injections. Royalties will begin to trickle in from now on. It is good to see the company hunkering ...
